Skip to main content
R
Brand Partner

ReCELLebrate

ReCELLebrate® is a U.S.-based regenerative medicine and wellness business headquartered in Henderson, Nevada. Founded by Dr. Jeff Gross, the company offers personalized consultations focused on regenerative medicine, longevity, joint health, and biohacking. Its approach emphasizes physician-guided education and individualized discussions about healthcare options, helping clients explore emerging approaches to wellness and healthy aging.

Visit Website
9,470+Total Reach
0 videos

About ReCELLebrate

ReCELLebrate® is a regenerative medicine and wellness business based in Henderson, Nevada, founded by Dr. Jeff Gross, a fellowship-trained neurological surgeon with a background in biochemistry and spine care. The company focuses on personalized healthcare consultations, regenerative medicine education, longevity, and health optimization. Its stated philosophy centers on helping individuals better understand their health goals and discuss potential care options with a medical professional.

Its services include consultations related to regenerative medicine, joint and musculoskeletal health, longevity medicine, and personalized biohacking strategies. The company also publishes educational material about stem-cell-related approaches, exosomes, and emerging regenerative technologies. ReCELLebrate’s team includes Dr. Gross and other healthcare professionals, with services designed for individuals seeking information about their options for mobility, recovery, and healthy aging.

ReCELLebrate serves clients through its website, consultations, and educational resources. Its positioning combines physician-led guidance with an interest in emerging regenerative approaches and proactive wellness. As the evidence and regulatory status of regenerative treatments vary, the company states that its materials are not intended to claim that stem cells, exosomes, or other regenerative biologics diagnose, treat, cure, or prevent disease. Prospective patients should discuss evidence, risks, regulatory status, and alternatives with a qualified clinician before making treatment decisions.